Works by Hosaka, Hisashi


Results: 23
    1

    Prognostic Nutrition Index as a Biomarker for Treatment Sensitivity to Chemotherapy and Nivolumab as the First-Line Treatment in Patients with Unresectable Advanced or Recurrent Gastric Cancer: A Multicenter Study.

    Published in:
    Oncology, 2025, v. 103, n. 6, p. 469, doi. 10.1159/000541544
    By:
    • Nakazawa, Nobuhiro;
    • Sano, Akihiko;
    • Kumakura, Yuji;
    • Yamashita, Toshiki;
    • Tanaka, Naritaka;
    • Saito, Kana;
    • Kimura, Akiharu;
    • Kasuga, Kengo;
    • Nakazato, Kenji;
    • Yoshinari, Daisuke;
    • Shimizu, Hisashi;
    • Ubukata, Yasunari;
    • Hosaka, Hisashi;
    • Shiraishi, Takuya;
    • Sakai, Makoto;
    • Sohda, Makoto;
    • Shirabe, Ken;
    • Saeki, Hiroshi
    Publication type:
    Article
    2
    3

    Addition of docetaxel to S-1 without platinum prolongs survival of patients with advanced gastric cancer: a randomized study (START).

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2014, v. 140, n. 2, p. 319, doi. 10.1007/s00432-013-1563-5
    By:
    • Koizumi, Wasaburo;
    • Kim, Yeul;
    • Fujii, Masashi;
    • Kim, Hoon;
    • Imamura, Hiroshi;
    • Lee, Kyung;
    • Hara, Takuo;
    • Chung, Hyun;
    • Satoh, Taroh;
    • Cho, Jae;
    • Hosaka, Hisashi;
    • Tsuji, Akihito;
    • Takagane, Akinori;
    • Inokuchi, Mikito;
    • Tanabe, Kazuaki;
    • Okuno, Tatsuya;
    • Ogura, Mariko;
    • Yoshida, Kazuhiro;
    • Takeuchi, Masahiro;
    • Nakajima, Toshifusa
    Publication type:
    Article
    4

    Identification of Biomarkers for Assessing Treatment Efficacy of Chemotherapy plus Nivolumab as the First Line in Patients with Unresectable Advanced or Recurrent Gastric Cancer: A Multicenter Study.

    Published in:
    Oncology, 2025, v. 103, n. 3, p. 201, doi. 10.1159/000540841
    By:
    • Nakazawa, Nobuhiro;
    • Sohda, Makoto;
    • Hosoi, Nobuhiro;
    • Watanabe, Takayoshi;
    • Kumakura, Yuji;
    • Yamashita, Toshiki;
    • Tanaka, Naritaka;
    • Saito, Kana;
    • Kimura, Akiharu;
    • Kasuga, Kengo;
    • Nakazato, Kenji;
    • Yoshinari, Daisuke;
    • Shimizu, Hisashi;
    • Ubukata, Yasunari;
    • Hosaka, Hisashi;
    • Sano, Akihiko;
    • Sakai, Makoto;
    • Ogawa, Hiroomi;
    • Shirabe, Ken;
    • Saeki, Hiroshi
    Publication type:
    Article
    5

    Efficacy and Safety of the Combination of Nano-Liposomal Irinotecan and 5-Fluorouracil/L-Leucovorin in Unresectable Advanced Pancreatic Cancer: A Real-World Study.

    Published in:
    Oncology, 2022, v. 100, n. 8, p. 449, doi. 10.1159/000525742
    By:
    • Yasuoka, Hidetoshi;
    • Naganuma, Atsushi;
    • Kurihara, Eishin;
    • Kobatake, Tsutomu;
    • Ijima, Masashi;
    • Tamura, Yuki;
    • Suzuki, Yuhei;
    • Hoshino, Takashi;
    • Ishida, Fumiya;
    • Hosaka, Hisashi;
    • Hatanaka, Takeshi;
    • Yoshida, Sachiko;
    • Aihara, Ryusuke;
    • Hosouchi, Yasuo;
    • Ishii, Norihiro;
    • Araki, Kenichiro;
    • Shirabe, Ken;
    • Uraoka, Toshio;
    • Kakizaki, Satoru
    Publication type:
    Article
    6
    7

    Phase IIb study of pembrolizumab combined with S‐1 + oxaliplatin or S‐1 + cisplatin as first‐line chemotherapy for gastric cancer.

    Published in:
    Cancer Science, 2022, v. 113, n. 8, p. 2814, doi. 10.1111/cas.15462
    By:
    • Yamaguchi, Kensei;
    • Minashi, Keiko;
    • Sakai, Daisuke;
    • Nishina, Tomohiro;
    • Omuro, Yasushi;
    • Tsuda, Masahiro;
    • Iwagami, Shiroh;
    • Kawakami, Hisato;
    • Esaki, Taito;
    • Sugimoto, Naotoshi;
    • Oshima, Takashi;
    • Kato, Ken;
    • Amagai, Kenji;
    • Hosaka, Hisashi;
    • Komine, Keigo;
    • Yasui, Hisateru;
    • Negoro, Yuji;
    • Ishido, Kenji;
    • Tsushima, Takahiro;
    • Han, Shirong
    Publication type:
    Article
    8
    9

    ASO Visual Abstract: Conversion Surgery After Chemotherapy Plus Nivolumab as the First-Line Treatment for Unresectable Advanced or Recurrent Gastric Cancer and a Biomarker Study Using the Gustave Roussy Immune Score—A Multicenter Study.

    Published in:
    2024
    By:
    • Nakazawa, Nobuhiro;
    • Sohda, Makoto;
    • Hosoi, Nobuhiro;
    • Watanabe, Takayoshi;
    • Kumakura, Yuji;
    • Yamashita, Toshiki;
    • Tanaka, Naritaka;
    • Saito, Kana;
    • Kimura, Akiharu;
    • Kasuga, Kengo;
    • Nakazato, Kenji;
    • Yoshinari, Daisuke;
    • Shimizu, Hisashi;
    • Ubukata, Yasunari;
    • Hosaka, Hisashi;
    • Sano, Akihiko;
    • Sakai, Makoto;
    • Ogawa, Hiroomi;
    • Shirabe, Ken;
    • Saeki, Hiroshi
    Publication type:
    Abstract
    10

    Conversion Surgery After Chemotherapy Plus Nivolumab as the First-Line Treatment for Unresectable Advanced or Recurrent Gastric Cancer and a Biomarker Study Using the Gustave Roussy Immune Score: A Multicenter Study.

    Published in:
    Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2024, v. 31, n. 13, p. 9023, doi. 10.1245/s10434-024-16161-4
    By:
    • Nakazawa, Nobuhiro;
    • Sohda, Makoto;
    • Hosoi, Nobuhiro;
    • Watanabe, Takayoshi;
    • Kumakura, Yuji;
    • Yamashita, Toshiki;
    • Tanaka, Naritaka;
    • Saito, Kana;
    • Kimura, Akiharu;
    • Kasuga, Kengo;
    • Nakazato, Kenji;
    • Yoshinari, Daisuke;
    • Shimizu, Hisashi;
    • Ubukata, Yasunari;
    • Hosaka, Hisashi;
    • Sano, Akihiko;
    • Sakai, Makoto;
    • Ogawa, Hiroomi;
    • Shirabe, Ken;
    • Saeki, Hiroshi
    Publication type:
    Article
    11
    12

    Changes in the Gustave Roussy Immune Score as a Powerful Prognostic Marker of the Therapeutic Sensitivity of Nivolumab in Advanced Gastric Cancer: A Multicenter, Retrospective Study.

    Published in:
    Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 12, p. 7400, doi. 10.1245/s10434-022-12226-4
    By:
    • Nakazawa, Nobuhiro;
    • Sohda, Makoto;
    • Ubukata, Yasunari;
    • Kuriyama, Kengo;
    • Kimura, Akiharu;
    • Kogure, Norimichi;
    • Hosaka, Hisashi;
    • Naganuma, Atsushi;
    • Sekiguchi, Masanori;
    • Saito, Kana;
    • Ogata, Kyoichi;
    • Sano, Akihiko;
    • Sakai, Makoto;
    • Ogawa, Hiroomi;
    • Shirabe, Ken;
    • Saeki, Hiroshi
    Publication type:
    Article
    13

    Differences in efficacy of biweekly irinotecan plus cisplatin versus irinotecan alone in second-line treatment of advanced gastric cancer with or without prior gastrectomy.

    Published in:
    International Journal of Clinical Oncology, 2025, v. 30, n. 2, p. 320, doi. 10.1007/s10147-024-02661-6
    By:
    • Nishikawa, Kazuhiro;
    • Koizumi, Wasaburo;
    • Tsuburaya, Akira;
    • Suzuki, Motoko;
    • Morita, Satoshi;
    • Fujitani, Kazumasa;
    • Akamaru, Yusuke;
    • Shimada, Ken;
    • Hosaka, Hisashi;
    • Nishimura, Ken;
    • Yoshikawa, Takaki;
    • Tsujinaka, Toshimasa;
    • Sakamoto, Junichi
    Publication type:
    Article
    14
    15

    Impact of gastrectomy on efficacy and safety of second‐line chemotherapy patients with advanced gastric cancer: Exploratory analysis of two randomized phase III trials.

    Published in:
    Annals of Gastroenterological Surgery, 2025, v. 9, n. 3, p. 429, doi. 10.1002/ags3.12880
    By:
    • Nishikawa, Kazuhiro;
    • Koizumi, Wasaburo;
    • Tsuburaya, Akira;
    • Suzuki, Motoko;
    • Morita, Satoshi;
    • Fujitani, Kazumasa;
    • Akamaru, Yusuke;
    • Shimada, Ken;
    • Hosaka, Hisashi;
    • Nishimura, Ken;
    • Yoshikawa, Takaki;
    • Tsujinaka, Toshimasa;
    • Sakamoto, Junichi
    Publication type:
    Article
    16
    17

    Multicenter phase II study of capecitabine plus oxaliplatin in older patients with advanced gastric cancer: the Tokyo Cooperative Oncology Group (TCOG) GI-1601 study.

    Published in:
    Gastric Cancer, 2023, v. 26, n. 6, p. 1020, doi. 10.1007/s10120-023-01423-z
    By:
    • Kawabata, Ryohei;
    • Chin, Keisho;
    • Takahari, Daisuke;
    • Hosaka, Hisashi;
    • Muto, Osamu;
    • Shindo, Yoshiaki;
    • Nagata, Naoki;
    • Yabusaki, Hiroshi;
    • Imamura, Hiroshi;
    • Endo, Shunji;
    • Kashiwada, Tomomi;
    • Nakamura, Masato;
    • Hihara, Jun;
    • Kobayashi, Michiya;
    • Sagawa, Tamotsu;
    • Saito, Soh;
    • Sato, Atsushi;
    • Yamada, Takeshi;
    • Okano, Naohiro;
    • Shimada, Ken
    Publication type:
    Article
    18

    Efficacy and safety of trifluridine/tipiracil in older and younger patients with metastatic gastric or gastroesophageal junction cancer: subgroup analysis of a randomized phase 3 study (TAGS).

    Published in:
    Gastric Cancer, 2022, v. 25, n. 3, p. 586, doi. 10.1007/s10120-021-01271-9
    By:
    • Shitara, Kohei;
    • Doi, Toshihiko;
    • Hosaka, Hisashi;
    • Thuss-Patience, Peter;
    • Santoro, Armando;
    • Longo, Federico;
    • Ozyilkan, Ozgur;
    • Cicin, Irfan;
    • Park, David;
    • Zaanan, Aziz;
    • Pericay, Carles;
    • Özgüroğlu, Mustafa;
    • Alsina, Maria;
    • Makris, Lukas;
    • Benhadji, Karim A.;
    • Ilson, David H.
    Publication type:
    Article
    19

    Correction to: Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trial.

    Published in:
    2021
    By:
    • Fujitani, Kazumasa;
    • Shitara, Kohei;
    • Takashima, Atsuo;
    • Koeda, Keisuke;
    • Hara, Hiroki;
    • Nakayama, Norisuke;
    • Hironaka, Shuichi;
    • Nishikawa, Kazuhiro;
    • Kimura, Yutaka;
    • Amagai, Kenji;
    • Hosaka, Hisashi;
    • Komatsu, Yoshito;
    • Shimada, Ken;
    • Kawabata, Ryohei;
    • Ohdan, Hideki;
    • Kodera, Yasuhiro;
    • Nakamura, Masato;
    • Nakajima, Takako Eguchi;
    • Miyata, Yoshinori;
    • Moriwaki, Toshikazu
    Publication type:
    Correction Notice
    20

    Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trial.

    Published in:
    Gastric Cancer, 2021, v. 24, n. 2, p. 467, doi. 10.1007/s10120-020-01131-y
    By:
    • Fujitani, Kazumasa;
    • Shitara, Kohei;
    • Takashima, Atsuo;
    • Koeda, Keisuke;
    • Hara, Hiroki;
    • Nakayama, Norisuke;
    • Hironaka, Shuichi;
    • Nishikawa, Kazuhiro;
    • Kimura, Yutaka;
    • Amagai, Kenji;
    • Hosaka, Hisashi;
    • Komatsu, Yoshito;
    • Shimada, Ken;
    • Kawabata, Ryohei;
    • Ohdan, Hideki;
    • Kodera, Yasuhiro;
    • Nakamura, Masato;
    • Nakajima, Takako Eguchi;
    • Miyata, Yoshinori;
    • Moriwaki, Toshikazu
    Publication type:
    Article
    21

    Meta-analysis of two randomized phase III trials (TCOG GI-0801 and ECRIN TRICS) of biweekly irinotecan plus cisplatin versus irinotecan alone as second-line treatment for advanced gastric cancer.

    Published in:
    Gastric Cancer, 2020, v. 23, n. 1, p. 160, doi. 10.1007/s10120-019-00990-4
    By:
    • Nishikawa, Kazuhiro;
    • Koizumi, Wasaburo;
    • Tsuburaya, Akira;
    • Yamanaka, Takeharu;
    • Morita, Satoshi;
    • Fujitani, Kazumasa;
    • Akamaru, Yusuke;
    • Shimada, Ken;
    • Hosaka, Hisashi;
    • Nakayama, Norisuke;
    • Tsujinaka, Toshimasa;
    • Sakamoto, Junichi
    Publication type:
    Article
    22
    23